Paul Gillette

Paul Gillette is a freelance writer based in Euclid, Ohio.

Articles

Suneva Medical has acquired a new product line, including worldwide rights to Refissa (tretinoin 0.05 percent), from Spear Pharmaceuticals.

Suneva acquires Spear product line

A person’s eye color may help to predict risk for vitiligo, according to results of a new study.

Eye color may predict vitiligo risk

A new study shows that a hormone that is associated with maintaining bone health may also help to boost antimicrobial peptide (AMP) expression when dietary vitamin D levels are low.

Study: Hormone plays role in fighting skin infections

Scientists have taken skin cells from patients with advanced heart failure and used them to create healthy, patient-specific heart muscle cells, according to results of a recent study.

Skin cells regenerated into beating heart cells

New research suggests aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) may help protect against skin cancer.

NSAIDs may protect against skin cancer

Another recent study has shown that the BRAF inhibitor dabrafenib is safe and effective in treating advanced melanoma.

Dabrafenib efficacious for metastatic melanoma

Swiss drugmaker Novartis has signed an agreement to acquire Fougera Pharmaceuticals for more than $1.5 billion in cash.

Novartis acquires pharmaceutical company

Data from an ongoing clinical evaluation of a combination of two drugs in patients with advanced melanoma is showing promise as a new way of treating the disease.

Drug combo shows promise against melanoma

A recently published study suggests vigorous exercise may be associated with a lower risk of psoriasis.

Brisk exercise may lower psoriasis risk

A watchdog organization has released a report indicating more than 50 percent of tested sunscreens contain ingredients that have the potential to cause cell damage and skin cancer.

Author | Paul Gillette

Articles

New content coming soon, please check back later.